IN THIS ISSUE
A MODEL FOR LIFE
Napoleone Ferrara identified vascular endothelial growth factor (VEGF) as a major regulator of blood vessel development. The antibodies that he and his colleagues created to block VEGF action also block cancer growth. Here, he discusses the work that led to the development of the anti-cancer drug Avastin (bevacizumab), and discusses the role of basic science in clinical medicine.
With international recognition as a premier medical institute, the Istituto Clinico Humanitas pulls disease questions from their patients in the clinic into their preclinical work in the lab investigates.